Explore all subjects

The Expertise Imperative and Compliance Technology
Access to a diverse array of specialized expert inputs drives superior decisions in every organizational context: within corporations, by investors and consultancies, and within nonprofits. When decision makers are confident of their decision inputs, they can respond more quickly and creatively to challenges and opportunities.Learn more about GLG's Compliance Framework


This page may include content provided by Council Members, your access to which is subject to the Terms of Use.
Find Out More

GLG News by Non-Electrophysiologist Cardiologists (US)

January 22, 2007
Applications
Analysis of: Portable drug anti-counterfeiting device to hit market (www.in-pharmatechnologist.com)
Breakthrough technology since RFID seems to have fizzled.
December 19, 2006
Generic Wellbutrin
Analysis of: IMPAX Announces FDA Approval of Generic Wellbutrin XL 300 mg (biz.yahoo.com)
Impact on GSK
Analysis of: Pfizer's Warning Signs (www.forbes.com)
1.  Delay of Merck's Niacin + Prostaglandin Inhibitor 2.  Delay of new cholesterol drugs 3.  Re-evaluation of Zetia/Vytorin
Analysis of: Cost-Effectiveness of Second-Generation Antipsychotics and Perphenazine in a Randomized Trial of Treatment for Chronic Schizophrenia (ajp.psychiatryonline.org)
1. Study showed equal effectiveness 2. Side effects are some greater
Analysis of: Merck Developing CETP Inhibitor (www.msnbc.msn.com)
The ILLUMINATE trial DSMB stopped the study because of the adverse events, but until we have more details about those outcomes it is hard to know whether this signals the failure of the strategy as a class, or a specific complication of this drug. It is perfectly possible to imagine that though torcetrapib...
Analysis of: End of Drug Trial Is a Big Loss for Pfizer and Heart Patients (www.nytimes.com)
I wrote on 11/10/06 that "...A clinical trial demonstrating that torcetrapib (in combination with atorvastatin) does increase HDL levels is a first step. Can we imagine, though, that this effect might not have the expected result on coronary artery events? The cardiovascular literature is full of examples...
Dale Mueller, M.D., Vice-Chairman of Cardiovascular Medicine
OSF Saint Francis Medical Center
December 4, 2006
Surgery does it better
Analysis of: Endarterectomy versus Stenting in Patients with Symptomatic Severe Carotid Stenosis (content.nejm.org)
This study investigated carotid endarterectomy versus carotid stenting in patients with severe carotid stenosis. The study was stopped prematurely due to safety and futility. The 30-day incidence of stroke or death was 3.9% versus 9.6% for endarterectomy versus carotid stenting. This data implies that...
Dale Mueller, M.D., Vice-Chairman of Cardiovascular Medicine
OSF Saint Francis Medical Center
Analysis of: Trading restenosis for Thrombosis? New questions about drug-eluding stents. (content.nejm.org)
This is a general commentary regarding coronary stent thrombosis and highlights the difficulties which Medtronic (Endeavor), Abbott (Xience V and Conor Medsystem (CoStar) may soon face with FDA approval of their new stents which are currently unavailable in the US. It also highlights that drug-coated...
Dale Mueller, M.D., Vice-Chairman of Cardiovascular Medicine
OSF Saint Francis Medical Center
Analysis of: Left Ventricular Assist Device and Drug Therapy for the Reversal of Heart Failure (content.nejm.org)
In a series of 15 patients, the Thoratec ventricular assist device was utilized with associated medical treatment for severe non-ischemic heart failure. Eleven of the fifteen patients recovered and avoided transplantation. Key implications include increased utilization of ventricular assist devices...
Dale Mueller, M.D., Vice-Chairman of Cardiovascular Medicine
OSF Saint Francis Medical Center
Analysis of: AHA Scientific Sessions - Percutaneous Devices for Aortic Valve Disease (www.cardiosource.com)
Percutaneous valves are technically feasible.Complications are currently not comparable to the traditional open valve replacement/repair.

Previous Page : 1 2 3 4 5 6 7 8 9 10 Next81 to 90 of 98

Analytics


Generated at 2009-01-07T19:00:58.307